
Loading, please wait...

Loading, please wait...

Emerging arboviral infections significantly threaten global transfusion systems. Consequently, healthcare providers must prioritize robust Arboviral blood safety measures to prevent the transmission of infectious agents. A recent international survey involving 21 countries evaluated how blood establishments manage these risks. The study analyzed data from nearly 30 million donations collected in 2024 to identify gaps in current safety protocols.
Researchers found that every respondent currently uses travel-based donor deferrals. However, this strategy alone may not remain sustainable during large-scale outbreaks. Extensive deferrals can drastically reduce the donor pool, leading to critical blood shortages. Furthermore, only half of the surveyed countries have implemented pathogen reduction technologies. These methods currently apply mostly to a selection of plasma and platelet donations rather than the entire supply.
Pathogen reduction technologies offer a universal safeguard by inactivating various viruses and bacteria. Despite their benefits, cost and logistical hurdles often impede their widespread adoption. West Nile virus (WNV) was the primary target for screening in the survey. While screening confirmed 256 WNV-positive donations, nine respondents noted that screening for other emerging viruses remains rare. Consequently, experts advocate for proactive risk assessments to determine if additional mitigation is necessary for viruses like Dengue, Chikungunya, and Zika.
In India, regulators are also enhancing safety standards. The Indian Pharmacopoeia 2026 now brings blood components under uniform standards to tighten oversight. This move, alongside the phased expansion of Nucleic Acid Testing (NAT), aligns with global efforts to modernize blood-safety architecture. Therefore, clinicians must stay updated on these evolving guidelines to ensure patient safety during transfusion therapy.
Donor deferral relies on identifying high-risk individuals, but large outbreaks can infect a significant portion of the population. This reduces the number of eligible donors. Consequently, relying solely on deferrals can cause severe blood supply shortages during epidemics.
Pathogen reduction technologies (PRTs) use chemical or light-based methods to inactivate pathogens within blood products. Unlike screening, which targets specific known viruses, PRTs provide a broad layer of protection against both known and emerging infectious agents.
No, current protocols are often limited. While many regions screen for West Nile Virus, screening for Dengue or Zika is not yet universal. Medical authorities recommend performing specific risk assessments to determine when additional screening or pathogen reduction is warranted.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


An international survey of 21 countries reveals that current arboviral blood safety measures are limited and unevenly distributed. While West Nile virus screening is established in some regions, growing threats from Dengue and Zika require urgent risk assessments and enhanced pathogen reduction strategies.
last month

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today